|
LOC148189 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.1983999982983E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.05700000044784E-07 |
| Normal-vs-Stage2 |
7.54430000000639E-05 |
| Normal-vs-Stage3 |
2.29639999999032E-05 |
| Normal-vs-Stage4 |
1.056510E-03 |
| Stage1-vs-Stage2 |
6.661400E-01 |
| Stage1-vs-Stage3 |
5.175600E-01 |
| Stage1-vs-Stage4 |
7.038200E-01 |
| Stage2-vs-Stage3 |
8.972600E-01 |
| Stage2-vs-Stage4 |
9.466000E-01 |
| Stage3-vs-Stage4 |
9.639000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.94310000054688E-07 |
| Normal-vs-AfricanAmerican |
1.81829999945649E-08 |
| Normal-vs-Asian |
4.567500E-02 |
| Caucasian-vs-AfricanAmerican |
2.232200E-01 |
| Caucasian-vs-Asian |
8.651400E-01 |
| AfricanAmerican-vs-Asian |
5.162800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.46909978310839E-10 |
| Normal-vs-Female |
3.243600E-03 |
| Male-vs-Female |
4.484700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.46590000005276E-06 |
| Normal-vs-Extreme_Weight |
1.98750000013348E-07 |
| Normal-vs-Obese |
1.817080E-04 |
| Normal-vs-Extreme_Obese |
6.715600E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.968200E-01 |
| Normal_Weight-vs-Obese |
3.032800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.380400E-01 |
| Extreme_Weight-vs-Obese |
1.221030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.895400E-01 |
| Obese-vs-Extreme_Obese |
7.024000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.471000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.55060000001295E-06 |
| Normal-vs-Age(61-80Yrs) |
1.55629999998297E-08 |
| Normal-vs-Age(81-100Yrs) |
3.57400000000618E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.559900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.141500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.052460E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.470000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.554000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.304200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.16679999995206E-06 |
| Normal-VS-Type2 PRCC |
3.57959994978785E-10 |
| Normal-VS-KIRP CIMP |
4.980800E-01 |
| Normal-VS-Unclassified PRCC |
1.983300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.095830E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.101800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.850800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.893800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.600100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.865700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92389999487119E-08 |
| Normal-vs-N1 |
2.846500E-04 |
| Normal-vs-N2 |
3.185800E-02 |
| N0-vs-N1 |
6.960800E-01 |
| N0-vs-N2 |
9.403400E-01 |
| N1-vs-N2 |
9.051600E-01 |
|
|
